Strategic Partnerships Lapsi Health is actively expanding across Europe and the U.S. and has recently partnered with eMurmur to enhance AI analytics. This signals openness to channel partnerships and co-development opportunities with AI and cardiac/pulmonary auscultation leaders.

Clinician-Focused AI Their Keikku platform combines digital auscultation, AI medical scribing, and generative clinical intelligence to transform clinical data capture. This presents a compelling upsell path to hospitals and clinics seeking workflow-integrated AI assistants and documentation efficiencies.

FDA-Ready Solutions With the FDA-approved Keikku smart stethoscope, there is a credible credibility signal for selling to U.S. healthcare providers and payer networks seeking compliant, clinically validated digital auscultation tools.

Digital Stethoscope upsell Recent launches of second-generation digital smart stethoscope and AI analytics integration create a cross-sell opportunity to existing customers for expanded sensing capabilities, analytics, and telemedicine workflows.

Fetal Health Wearable The Ilo fetal wearable development indicates adjacent product lines that can be pitched to obstetrics, maternal-fetal medicine departments, and clinics focusing on pregnancy monitoring, opening niche market entry points and bundled solutions.